Cefdinir-associated "bloody stools" in an infant

Area of Science:

• Pediatric Pharmacology
• Gastroenterology

Background:

• Cefdinir is a widely prescribed third-generation cephalosporin antibiotic for pediatric infections.
• Concurrent administration of cefdinir with iron-containing products is common in infants.
• A benign gastrointestinal side effect of red stools is not well-documented.

Observation:

• A case study involving a 7-month-old female infant is presented.
• The infant presented with red stools during treatment with cefdinir.
• The infant was also receiving an oral iron supplement.

Findings:

• The red stools were attributed to the interaction between cefdinir and oral iron.
• This interaction leads to the formation of a non-absorbable cefdinir-iron complex.
• The condition is benign and resolves upon discontinuation of the medication or iron supplement.

Implications:

• Clinicians should be aware of this potential cefdinir-iron interaction.
• Educating parents about this benign side effect can prevent unnecessary concern and medical visits.
• Further research is warranted to understand the prevalence and mechanisms of this interaction.